Join Predicine at the 2024 SUO in Dallas, TX from December 4-6! Visit us at our booth to discover our groundbreaking urinary liquid biopsy solutions, offering unparalleled insights through genomic profiling and MRD detection. Schedule a meeting: outlook.office365.com/book/MeetingSU…

November is National Stomach Cancer Awareness Month Stomach cancer often develops without obvious symptoms in the early stages, making awareness & education crucial. Let’s spread the word on the importance of early detection, knowing risk factors, & supporting ongoing research

November is Lung Cancer Awareness Month. Lung cancer is the 2nd most common cancer worldwide. At Predicine, we’re committed to advancing the fight against lung cancer through groundbreaking precision diagnostics & innovative treatments.

Join Predicine at the 2024 SITC in Houston, TX from November 6-10! Visit us at booth #641 to discover how our innovative liquid biopsy solutions accelerate drug development. Schedule a meeting with us here: outlook.office365.com/book/MeetingSI…

November is Pancreatic Cancer Awareness Month This month, let’s join forces to raise awareness about the risks, symptoms, and treatment options for pancreatic cancer while supporting critical, life-saving research.

Join Predicine at the 2024 36th EORTC-NCI-AACR Symposium in Barcelona, Spain, from October 23-25! Visit us at booth #19 Schedule a meeting with us here: outlook.office365.com/book/MeetingEN… Learn more about Predicine: online.flippingbook.com/view/403420724/

October is Breast Cancer Awareness Month Early detection plays a crucial role. Learn more about how Predicine’s liquid biopsy technology is transforming personalized breast cancer care: pubmed.ncbi.nlm.nih.gov/38183515/

Predicine is in Pennsylvania, attending the Merck Technology Symposium! Connect with our team at booth 625 to learn how Predicine's Accurate, Accessible, and Affordable (AAA) liquid biopsy solutions can empower your global clinical trials across the US, EU, Japan, China & beyond

Attending ESMO 2024 in Barcelona? Visit Predicine at booth #419 to learn how the PredicineCARE™ cfDNA assay is advancing clinical trials and providing valuable insights into HR+/HER2- breast cancer with comprehensive genetic profiling.

Join us at #ESMO24 9/15 to unveil 7 groundbreaking liquid biopsy studies. Discover the role of the PredicineCARE™ urine cfDNA assay in NMIBC patient selection. Explore how urine-based PredicineBEACON™ personalized MRD assay is revolutionizing treatment response monitoring.

Predicine is in Barcelona, Spain, attending #ESMO24! Connect with our team at booth #419 to learn how Predicine's Accurate, Accessible, and Affordable (AAA) liquid biopsy solutions can empower your global clinical trials across the US, EU, Japan, China, and beyond.

Join us at #ESMO2024 for Dr. Matteo Simonelli's oral session Phase 1 clinical trial of INCB123667, a selective CDK2 inhibitor by Incyte, in advanced solid tumors. Discover key insights into therapy monitoring powered by PredicineSCORE™, a low-pass whole-genome sequencing assay.

Attending #ESMO2024 in Barcelona? Join us at booth #419 to explore 9 ctDNA studies showcasing the clinical utility of Predicine liquid biopsy platform in treatment selection, molecular response, MRD detection, drug resistance, and CDx development.

Attending #WCLC2024 in San Diego? Join Predicine Booth #1420! Discover our cutting-edge liquid biopsy solutions, including PredicineBEACON™ MRD, PredicineALERT™ MRD, and NYS-approved PredicineCARE™ for global #CDx development. Don’t miss out! #LungCancer

Attending #WCLC2024 in San Diego? Join Predicine Booth #1420! Discover our cutting-edge liquid biopsy solutions, including PredicineBEACON™ MRD, PredicineALERT™ MRD, and NYS-approved PredicineCARE™ for global #CDx development. Don’t miss out! 🌍 #LungCancer #Oncology #MRD #CDx

As we mark September as #ProstateCancerAwarenessMonth, it's vital to raise awareness and enhance education about this disease. Read about how Predicine liquid biopsy technology innovation is impacting personalized prostate cancer care: thelancet.com/journals/ebiom…

Join us at ESMO 2024 in Barcelona, Spain! Predicine is thrilled to be exhibiting and showcasing 7 groundbreaking poster presentations! Meet our team on site booth #419 or virtually and see how Predicine technology can help contribute to your program. outlook.office365.com/book/Meetingwi…

PredicineCARE™, provides critical insights into treatment efficacy & resistance mechanisms. This study, recently published in Nature Medicine, underscores PredicineCARE™'s pivotal role in supporting Incyte's Phase II basket trial. View publication here: nature.com/articles/s4159…

Discover how monitoring TF provides crucial insights into treatment response with our actionable MRD assay, PredicineBEACON™, in tracking & predicting therapeutic efficacy in Roche's clinical trials for KRAS G12C inhibitor, Divarasib. View publication: aacrjournals.org/clincancerres/…

Explore how Predicine's state-of-the-art liquid biopsy platforms provide comprehensive cancer analysis for treatment selection, response monitoring, and resistance detection in advanced HER2+ gastroesophageal adenocarcinoma patients. View publication: nature.com/articles/s4146…